COVID-19

News

Pfizer begins US pilot delivery programme for COVID-19 vacci...

Pfizer has begun a pilot delivery programme in the US for its experimental COVID-19 vaccine, as the company seeks to overcome logistical challenges caused by its ultra-cold storage requirem

News

scientifically visualization of a coronavirus spike protein

UK groups get £12m funding for COVID-19 monitoring software

Researchers at the Wellcome Sanger Institute in the UK are working on software to monitor the genome of SARS-CoV-2 coronavirus in the hope of spotting changes that could affect the fight ag

Views & Analysis

Vertex Pharma’s vision for reimbursement innovation

As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s novel cystic fibrosis drug Kaftrio.

News

Could an antidepressant be used to treat COVID-19?

The antidepressant fluvoxamine merits further investigation as a potential treatment for COVID-19 according to findings of a preliminary trial.

News

UK eyes access deal as Moderna’s COVID-19 shot hits the mark

Moderna is the third group in a week to report encouraging phase 3 data with a coronavirus vaccine, saying today that its mRNA-1273 shot had an efficacy of 94.5% in the 30,000-patient COVE

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J begins trial of two-dose COVID-19 vaccine regimen

Johnson & Johnson has begun a second phase 3 trial of its potential COVID-19 vaccine, including sites in the UK, testing whether it works as a two-dose regimen.

Pfizer begins US pilot delivery programme for COVID-19 vacci...

UK groups get £12m funding for COVID-19 monitoring software

Vertex Pharma’s vision for reimbursement innovation

Could an antidepressant be used to treat COVID-19?

UK eyes access deal as Moderna’s COVID-19 shot hits the mark

J&J begins trial of two-dose COVID-19 vaccine regimen

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks